REYSTORDYS
Live / Applied — New application — not yet assigned to an examiner (as of 16 Dec 2025)
What this means for you
Not registered yet, but its 16 Dec 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99550037
- Mark type
- Stylized text
- Filed
- 16 Dec 2025
- Attorney of record
- William R. Samuels
Goods and services
- Class 005 — Pharmaceuticals: Biological preparations for medical use in the treatment of genetic diseases and disorders, and muscle disorders, namely, Duchenne muscular dystrophy; Pharmaceutical preparations, namely, recombinant adeno-associated viral (rAAV) vectors for use in gene therapy; Pharmaceutical preparations for the treatment of genetic diseases and disorders, and muscle disorders, namely, Duchenne muscular dystrophy; Clinical medical reagents for use in gene therapy; Therapeutic pharmaceutical compositions that include recombinant adeno-associated viral (rAAV) vectors to provide a platform for specific expression of biologics with therapeutic effect in gene therapy; Pharmaceutical preparations containing adeno-associated viral (AAV) vectors and nucleic acids for a system delivering genes to biological cells for use in the treatment of genetic diseases and disorders, namely, Duchenne muscular dystrophy; Gene therapy preparation for medical use containing genetic materials for sustained protein expression, namely, microdystrophin expression
Owner
- REGENXBIO Inc., Rockville, MD, US
Prosecution history
- 16 Dec 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 16 Dec 2025 — APPLICATION FILING RECEIPT MAILED
- 16 Dec 2025 — NEW APPLICATION ENTERED